Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 18.829\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) Cc1cc(=O)n(C)c(=O)n1CCCCOc1ccc([N+](=O)[O-])cc1
(b) Cc1cc(C)c(OCC(=O)OCC(=O)N2CCN(C(=O)c3ccco3)CC2)c(C)c1
(c) O=C(Nc1ccc(N2CCN(C(=O)c3cccs3)CC2)cc1)c1ccc([N+](=O)[O-])o1
(d) CCn1cc(CCC(=O)NCCN2CCOCC2)c2ccccc21
(e) CC(=O)N1CCN(C(=O)c2ccc(NS(=O)(=O)c3ccc4[nH]c(=O)[nH]c4c3)cc2)CC1
Answer: d. CCn1cc(CCC(=O)NCCN2CCOCC2)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1cc(CCC(=O)NCCN2CCOCC2)c2ccccc21
CCn1cc(CCC(=O)NCCN2CCOCC2)c2ccccc21
3-(1-ethylindol-3-yl)-N-(2-morpholin-4-ylethyl)propanamide